Targacept Inc. (TRGT) Profile

Profile for Targacept Inc. (TRGT)

After Hours: $ 6.11

0.04 (+0.66%)

Volume: 670

4:27 PM EST Feb 10, 2012


Business Description: A biopharmaceutical company, which is engaged in the design, discovery and development of NNR Therapeutics, a new class of drugs for the treatment of diseases and disorders of the central nervous system.

Address:	200 East 1st Street, Suite 300, Winston-Salem, NC, 27101-4165
Telephone:	(336) 480-2100	Website:	www.targacept.com
Facsimile:	(336) 480-2107	Email:	alan.musso@targacept.com


Details

CEO:	Dr. J. Donald deBethizy,PhD
Employees:	132	Market Cap:	202.64 m
Issue Type:	CS
Auditor:	Ernst & Young LLP
Last Audit:	Unqualified
Indices:	Biotechnology


Industry Classifications

Sector:	Healthcare	CIK:	0001124105
Industry:	Drugs
Sub-Industry:	Biotechnology
NAICS:	Pharmaceutical Preparation Manufacturing (325412)
SIC:	Pharmaceutical Preparations (2834)

Tags for Targacept Inc.

Research stocks or mutual funds related to Targacept Inc. by keywords or tags. Find companies that have a similar focus to TRGT. The keywords below have been associated to TRGT by either user submission or electronic means.

biotechnology company biotech research pharmaceutical market pharmaceuticals companies generic pharmaceutical pharmaceutical investment biotechnology market pharmaceutical research and development dupont pharmaceuticals pharma marketing pharmaceutical industry marketing pharmaceutical software pharma manufacturing pharma license pfizer pharmaceutical company pharmaceutical cro biopharmaceutical companies pharma companies pharma consulting pharma consultants pharmaceutical distributors company patent biotech pharmaceutical company pharmaceutical development biopharmaceutical company pharmaceutical magazine pharmaceutical consultant Drugs pharmaceutical auctions pharma r&d pharmaceutical industry news pharmaceutical manufacturing software pharmaceutical manufacturing pharma reports contract pharmaceutical pharmaceutical consulting pharmaceutical medical packaging news pharmaceutical industry biopharmaceutical market clinical trials europe acetylcholine patent research pharmaceutical advances pharmaceutical distributor pharmaceutical out licensing pharmaceutical business development Healthcare medical and pharmaceutical packaging pharmaceutical sector bio pharmaceuticals

Financial Market Data powered by QuoteMedia.com. All rights reserved. View the Terms of Use
NYSE/AMEX data delayed 20 minutes. NASDAQ and other data delayed 15 minutes unless indicated.
RT Realtime, EOD End Of Day, PD Previous Day. PW Previous Week.

All information displayed and available herein is on an "as is", "as available" basis and neither InvestorPoint.com nor any of its underlying service providers, information providers, licensors, employees, distributors or agents make any representations as to the suitability of our service or the materials for any purpose. The information is not intended for trading purposes or advice. We specifically disclaim any representations or warranties, express or implied, including, without limitation, any representations or warranties of merchantability or fitness for a particular purpose. InvestorPoint.com is not an investment adviser. We do not: (a) give investment advice, (b) advocate the purchase or sale of any security or investment and (c) provide, endorse or review any information or data contained herein. We do not guarantee the accuracy of the information and data supplied by information providers. We are not liable or responsible for the quality, accuracy or reliability of this information. You should always seek the assistance of a professional for investment advice.